Rutgers Business School (RBS) offers a leading M.B.A. program for health care, pharmaceutical, and biotech professionals, an education bolstered by the school's proximity and its connections to the hub of industry activity in New Jersey.
RBS partners with such companies as Bayer, Bristol-Myers Squibb, Eisai, Johnson & Johnson, and Novartis to provide M.B.A. students focused on pharmaceutical management with distinct advantages. The partnerships help to support a prestigious industry scholars program that provides scholarships to cover in- or out-of-state tuition for eligible students, offers meaningful internship opportunities, and enhances employment prospects with industry giants.
The Rutgers M.B.A. in pharmaceutical management, which was developed with full participation of top industry executives, is a 60-credit master of business administration, including 18 credits in pharmaceutical industry and pharmaceutical marketing. Elective courses in the concentration are open to all students enrolled at RBS.
Full-Time MBA concentration in Pharmaceutical Management | Rutgers Business School
Concentrations 
